DarioHealth COO reports ownership of 120,000 shares

DarioHealth Corp. (DRIO) Chief Operating Officer Lara Ann Sherman reported direct ownership of 120,000 common shares, including 95,000 restricted shares granted September 24, 2026, which vest on the second anniversary of the grant date.

Rhea-AI Filing Summary

DarioHealth Corp. (DRIO) Chief Operating Officer Lara Ann Sherman reported direct ownership of 120,000 common shares, including 95,000 restricted shares granted September 24, 2026, which vest on the second anniversary of the grant date. She also reported a stock option covering 15,000 common shares, with a $16 exercise price and a December 23, 2034 expiration date; 8,750 option shares were vested as of September 24, 2026.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Sherman Lara Ann

Role Chief Operating Officer

Type	Security	Shares	Price	Value
holding	Stock Option F2	--	--	--
holding	Common Stock F1	--	--	--

Holdings After Transaction: Stock Option — 15,000 contracts (Direct); Common Stock — 120,000 shares (Direct)

Footnotes (2)

1. F1. Includes 95,000 shares of restricted Common Stock granted to the Reporting Person on September 24, 2026, which vest on the second anniversary of the grant date.
2. F2. The option to purchase 15,000 shares of Common Stock was granted on December 23, 2024. The option vested as to 5,000 shares on December 2, 2025, and the remaining shares vest in eight quarterly installments of 1,250 shares each thereafter, subject to the Reporting Person's continued service through each applicable vesting date. As of September 24, 2026, the option was vested as to 8,750 shares.

Key Figures

Direct common shares reported: 120,000 shares Restricted shares granted: 95,000 shares Stock option underlying shares: 15,000 common shares +2 more

5 metrics

Direct common shares reported 120,000 shares Reported by Lara Ann Sherman

Restricted shares granted 95,000 shares Granted September 24, 2026; vest on the second anniversary of the grant date

Stock option underlying shares 15,000 common shares Option reported by Lara Ann Sherman

Exercise price $16 per share Stock option

Option shares vested 8,750 shares As of September 24, 2026

Key Terms

restricted Common Stock, quarterly installments, exercise price

3 terms

restricted Common Stock financial

"95,000 shares of restricted Common Stock granted"

Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.

quarterly installments financial

"vest in eight quarterly installments of 1,250 shares each"

exercise price financial

"The option has a $16 exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares does DarioHealth (DRIO) COO Lara Ann Sherman report?

Lara Ann Sherman reported direct ownership of 120,000 DarioHealth common shares, including 95,000 restricted shares granted September 24, 2026. Those restricted shares vest on the second anniversary of the grant date.

What are the terms of Lara Ann Sherman's DRIO stock option?

The option covers 15,000 common shares and has a $16 exercise price and a December 23, 2034 expiration date. It was granted December 23, 2024; 5,000 shares vested December 2, 2025, and the remaining shares vest in eight quarterly installments of 1,250 shares each, subject to continued service through each applicable vesting date. As of September 24, 2026, 8,750 shares were vested.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 04:06 PM Accepted by SEC EDGAR 09/28/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Sherman Lara Ann

(Last) (First) (Middle)

322 W 57TH ST, #33B

(Street)

NEW YORK NEW YORK 10019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/24/2026

3. Issuer Name and Ticker or Trading Symbol
DarioHealth Corp. [ DRIO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	120,000(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	12/02/2025	12/23/2034	Common Stock	15,000(2)	$16	D

Explanation of Responses:

1. Includes 95,000 shares of restricted Common Stock granted to the Reporting Person on September 24, 2026, which vest on the second anniversary of the grant date.

2. The option to purchase 15,000 shares of Common Stock was granted on December 23, 2024. The option vested as to 5,000 shares on December 2, 2025, and the remaining shares vest in eight quarterly installments of 1,250 shares each thereafter, subject to the Reporting Person's continued service through each applicable vesting date. As of September 24, 2026, the option was vested as to 8,750 shares.

	/s/ Lara Ann Sherman	09/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)